PMDA Perspective on RWD / RWE Utilization for Regulatory Purposes Including Assessment on the Impacts of Regulatory Actions and Safety Risk of a Drug at Postmarketing Stage
Pharmacoepidemiology and Drug Safety · 2024-09 · 33 (9)
DOI: 10.1002/pds.70007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, online erschienen am 06.09.2024. Verfasst von Kazuhiro Kajiyama und 4 weiteren Autor:innen. Beteiligte Einrichtung: Office of Pharmacovigilance I, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan. Hauptthemen laut MEDLINE: Product Surveillance, Postmarketing. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Office of Pharmacovigilance I, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
- Office of Regulatory Science Research, Center for Regulatory Science, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
- Office of Pharmacovigilance II, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
- Center for Regulatory Science, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
ORCID-Profile: Maki Komamine, Yoshiaki Uyama
Zitieren
APA
Kajiyama, K., Komamine, M., Horiuchi, N., Iguchi, T., & Uyama, Y. (2024). PMDA Perspective on RWD / RWE Utilization for Regulatory Purposes Including Assessment on the Impacts of Regulatory Actions and Safety Risk of a Drug at Postmarketing Stage. Pharmacoepidemiology and Drug Safety, 33(9). https://doi.org/10.1002/pds.70007
Vancouver
Kajiyama K, Komamine M, Horiuchi N, Iguchi T, Uyama Y. PMDA Perspective on RWD / RWE Utilization for Regulatory Purposes Including Assessment on the Impacts of Regulatory Actions and Safety Risk of a Drug at Postmarketing Stage. Pharmacoepidemiology and Drug Safety. 2024;33(9). doi:10.1002/pds.70007
BibTeX
@article{Kajiyama2024,
author = {Kajiyama, Kazuhiro and Komamine, Maki and Horiuchi, Naoya and Iguchi, Toyotaka and Uyama, Yoshiaki},
title = {PMDA Perspective on RWD / RWE Utilization for Regulatory Purposes Including Assessment on the Impacts of Regulatory Actions and Safety Risk of a Drug at Postmarketing Stage},
journal = {Pharmacoepidemiology and Drug Safety},
year = {2024},
volume = {33},
number = {9},
doi = {10.1002/pds.70007}
}
EUVIMED